Your browser doesn't support javascript.
loading
Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age, 2013-2019.
Kobernik, Emily K; Ford, Nicole D; Levecke, Madison; Galang, Romeo R; Hoots, Brooke; Roehler, Douglas R; Ko, Jean Y.
Afiliación
  • Kobernik EK; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ford ND; CDC Foundation, Atlanta, GA, USA.
  • Levecke M; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Galang RR; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Hoots B; Oak Ridge Institute for Science and Education, ORISE Fellow, Oak Ridge, TN, USA.
  • Roehler DR; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ko JY; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Subst Use Misuse ; 59(5): 690-698, 2024.
Article en En | MEDLINE | ID: mdl-38132561
ABSTRACT

BACKGROUND:

Marijuana is the most commonly used federally illicit substance among reproductive-age women in the United States. Updated information on marijuana use in this population can inform clinical and public health interventions.

METHODS:

Data from the 2013-2019 National Survey on Drug Use and Health was used to report weighted prevalence estimates of marijuana use in the past month, past 2-12 months, and past year among women aged 18-44 years with self-reported pregnancy status. Bivariate analyses and general linear regression models with Poisson distribution using appropriate survey procedures identified factors associated with past-year marijuana use by pregnancy status.

RESULTS:

Among pregnant women, 4.9% (95% confidence interval [CI] 4.1-5.6) reported marijuana use in the past month, 10.4% (95% CI 9.3-11.5) in the past 2-12 months, and 15.2% (95% CI 13.9-16.6) in the past year. Among nonpregnant women, 11.8% (95% CI 11.5-12.0) reported marijuana use in the past month, 7.8% (95% CI 7.6-8.0) in the past 2-12 months, and 19.5% (95% CI 19.2-19.9) in the past year. After adjusting for sociodemographic characteristics, past-year marijuana use was 2.3-5.1 times more likely among pregnant, and 2.1 to 4.6 times more likely among nonpregnant women who reported past-year tobacco smoking, alcohol use, or other illicit drug use compared to those reporting no substance use.

CONCLUSIONS:

Pregnant and nonpregnant women reporting marijuana use, alone or with other substances, can benefit from substance use screening and treatment facilitation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fumar Marihuana / Trastornos Relacionados con Sustancias / Uso de la Marihuana Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Subst Use Misuse / Subst. use misuse / Substance use and misuse Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fumar Marihuana / Trastornos Relacionados con Sustancias / Uso de la Marihuana Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Subst Use Misuse / Subst. use misuse / Substance use and misuse Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido